SDI Ltd
ASX:SDI

Watchlist Manager
SDI Ltd Logo
SDI Ltd
ASX:SDI
Watchlist
Price: 0.855 AUD Market Closed
Market Cap: AU$101.6m

SDI Ltd
Investor Relations

SDI Ltd. engages in the research, development, manufacturing, and marketing of dental restorative products, tooth whitening systems, and small dental equipment for sale to dental distributors, dental dealers and dentists worldwide. The company is headquartered in Bayswater, Victoria. The company manufactures dental restorative products, tooth whitening systems and small dental equipment for sale to dental distributors, dental dealers and dentists around the world. The firm's segments include Australia, Europe, United States and Brazil. Australia segment includes SDI Limited and SDI Dentech Innovations Pty Limited. Europe segment includes SDI Germany GmbH (Germany) and SDI Dental Innovations Limited (United Kingdom). United States segment includes SDI (North America), Inc. Brazil segment includes SDI Brasil Industria e Comercio Ltda. The firm's product categories include alloys, etchants, adhesives, glass ionomers, sealants, composites, cements, tooth whitening, equipment, accessories and SDF Riva Star. Its products are distributed through distributors and retailers in over 100 countries.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2024
Call Date
Feb 28, 2024
AI Summary
Q2 2024

Record Revenue: SDI delivered record half-year sales of $52.2 million, up 3.5% from the prior year.

Profitability Up: Gross profit margin rose sharply by 530 bps to 61.5%, and EBITDA jumped 48.9% to $9 million.

Expense Control: Strong expense management contributed to improved profitability despite moderate inflationary pressures.

Product Mix Shift: Continued decline in Amalgam sales, with growth focused on higher-margin Aesthetics products.

Montrose Project: Warehouse relocation completed; full site redevelopment and automation investments underway targeting $200 million sales capacity with a 20%+ ROI over 4 years.

Regulatory Progress: Confident in meeting new European registration requirements and sees high barriers to entry as an advantage.

No Formal Guidance: Management did not provide explicit second-half guidance but expects continuation of current trends.

Key Financials
Revenue
$52.2 million
Gross Profit Margin
61.5%
EBITDA
$9 million
Net Profit After Tax
$3.7 million
Final Dividend Per Share
$0.015 per share
Operating Cash Flow
$7.9 million
Impairment Expense
$700,000
Cash
$7.1 million
Bank Facility Headroom
$6 million
Return on Investment (Montrose Project)
greater than 20% pretax
Montrose Project Total Cost
$60 million
Earnings Call Recording
Other Earnings Calls
2024
2020

Management

Mr. Jeffery James Cheetham O.A.M., OAM
Founder & Chairman
No Bio Available
Ms. Samantha Jane Cheetham M.B.A.
CEO, MD & Executive Director
No Bio Available
Mr. John Joseph Slaviero B.Bus., CPA, F.T.M.A.
CFO, COO, Company Secretary & Executive Director
No Bio Available
Mr. Nicholas Alexander Cheetham
Chief Information Officer and Operations & IT Director
No Bio Available
Mr. Ray M. Cahill
Chief Quality & Compliance Officer
No Bio Available
Mr. Thomas Cheetham
Sales Manager of Australia, New Zealand & South Africa
No Bio Available

Contacts

Address
VICTORIA
Bayswater
3-13 Brunsdon St
Contacts
+61387277111.0
www.sdi.com.au